J. M. Plana

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

M. Emdin, N. Sarswat, C. Rapezzi, 2022, Orphanet Journal of Rare Diseases.

Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

S. Gottlieb, C. Rapezzi, L. Amass, 2021, Neurology and Therapy.

Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.

J. Moratalla, G. F. Fresnedo, M. Rodríguez, 2012 .

Atypical hemolytic uraemic syndrome

S. R. Córdoba, J. M. Plana, M. B. Pelícano, 2015 .

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update

M. Benson, P. Dyck, M. Gertz, 2022, Journal of Neurology.

Wnt-1 as a biomarker of kidney damage.

E. Bañon-maneus, J. M. Plana, L. F. Q. Porras, 2008 .